Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexJagath R. Junutula, William Mallet, Yvonne Chen et al.|Nature Biotechnology|2008Cited by 1.4k
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesBen‐Quan Shen, Jagath R. Junutula, Keyang Xu et al.|Nature Biotechnology|2012Cited by 997
Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug SelectionAndrew G. Polson, Allen Ebens, Jill Calemine-Fenaux et al.|Cancer Research|2009Cited by 248